Evidence-based recommendations on the My5‑FU assay for measuring levels of 5‑flurouracil (5‑FU) in patients having chemotherapy, to help guide changes to the dose of 5‑FU.

Is this guidance up to date?

We reviewed the evidence in February 2018. We found nothing new that affects the recommendations in this guidance.

Next review: This guidance will be reviewed if there is new evidence that is likely to change the recommendations.

Guidance development process

How we develop NICE diagnostics guidance

  • National Institute for Health and Care Excellence (NICE)